Tina Saren
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Trogocytosis of chimeric antigen receptors between T cells is regulated by their transmembrane domains.
Journal: Science immunology
Published: January 31, 2025
Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas.
Journal: Cancer immunology, immunotherapy : CII
Published: August 26, 2024
Correction to: Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: May 19, 2023
Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 20, 2023
Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: June 17, 2022
Complementarity-determining region clustering may cause CAR-T cell dysfunction.
Journal: Nature communications
Published: December 20, 2021
Tumor-Targeted Delivery of the p53-Activating Peptide VIP116 with PEG-Stabilized Lipodisks.
Journal: Nanomaterials (Basel, Switzerland)
Published: March 20, 2020
Insertion of the Type-I IFN Decoy Receptor B18R in a miRNA-Tagged Semliki Forest Virus Improves Oncolytic Capacity but Results in Neurotoxicity.
Journal: Molecular therapy oncolytics
Published: June 15, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026